Cowen Starts Kezer Life Sciences (KZR) at Outperform

Go back to Cowen Starts Kezer Life Sciences (KZR) at Outperform

Wells Fargo Starts Kezer Life Sciences (KZR) at Outperform

July 16, 2018 5:25 AM EDT

Wells Fargo initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating and a price target of $30.00.

Analyst Jim Birchenough comments "Our positive rating and outlook is based on what we view as a highly leverageable platform and pipeline of novel immunoproteasome inhibitors... More

Jefferies Starts Kezer Life Sciences (KZR) at Buy

July 16, 2018 5:20 AM EDT

Jefferies initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Buy rating.

For an analyst ratings summary and ratings history on Kezer Life Sciences click here. For more ratings news on Kezer Life Sciences click here.

Shares of Kezer Life Sciences closed at $15.80 yesterday.

... More

William Blair Starts Kezer Life Sciences (KZR) at Outperform

July 16, 2018 5:19 AM EDT

William Blair initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating.

For an analyst ratings summary and ratings history on Kezer Life Sciences click here. For more ratings news on Kezer Life Sciences click here.

Shares of Kezer Life Sciences closed at $15.80 yesterday.

... More